FDA Import Refusal AEK-7444787-8/11/1 — Aurobindo Pharma Limited

Aurobindo Pharma Limited — FEI 3003493712

The FDA refused shipment AEK-7444787-8/11/1 from Aurobindo Pharma Limited (India) on June 4, 2020. The refused product falls under Drugs and Biologics — LOPINAVIR; RITONAVIR (ANTI-VIRAL). Cited charge: 75 This firm has 5 or more other import refusals on record.

Refusal Details

Date
June 4, 2020
Country
India
Product Category
Drugs and Biologics
Product Code
62VDY79 LOPINAVIR; RITONAVIR (ANTI-VIRAL)
Charges
75